Skip to search formSkip to main contentSkip to account menu

Padeliporfin

A vascular-acting photosensitizer consisting of a water-soluble, palladium-substituted bacteriochlorophyll derivative with potential antineoplastic… 
National Institutes of Health

Related topics

Related topics

2 relations
NCIt Antineoplastic Agent Terminology

Narrower (1)

Palladium-Bacteriochlorophyll Derivative WST11

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Erectile function after WST11 vascular-targeted photodynamic therapy for low-risk prostate cancer treatment
Vascular-targeted photodynamic therapy (VTP) using padeliporfin is currently assessed as a low-risk prostate cancer (LRPCa… 
2017
2017
Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer.
2017
2017
Re: Padeliporfin Vascular-Targeted Photodynamic Therapy versus Active Surveillance in Men with Low-Risk Prostate Cancer (CLIN1001 PCM301): An Open-Label, Phase 3, Randomised Controlled Trial.
2017
2017
Commentary on: Padeliporfin Vascular-targeted Photodynamic Therapy Versus Active Surveillance in Men With Low-risk Prostate Cancer (CLIN1001 PCM301): An Open-label, Phase 3, Randomized Controlled…
2017
2017
Photodynamische Lokaltherapie versus Active Surveillance beim Niedrigrisiko-Prostatakarzinom
Fokale Therapien sind eine zunehmend interessante Alternative zur aktiven Beobachtung beim Niedrigrisiko-Prostatakarzinom. Für… 
2017
2017
Photodynamische Lokaltherapie versus Active Surveillance beim Niedrigrisiko-Prostatakarzinom
Fokale Therapien sind eine zunehmend interessante Alternative zur aktiven Beobachtung beim Niedrigrisiko-Prostatakarzinom. Für… 
2016
2016
Vascular targeted photodynamic treatment is effective in low risk prostate cancer, study finds
A new treatment using a cytotoxic drug activated by lasers that target the prostate halved the progression of prostate cancer… 
2010
2010
936 TOOKAD ® SOLUBLE (PADELIPORFIN) SECOND GENERATION VASCULAR TARGETED PHOTODYNAMIC THERAPY (VTP) FOR PROSTATE CANCER: SAFETY AND FEASIBILITY
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)